Adaptogenics Health

Adaptogenics Health Forward P/E

The Forward P/E Ratio of Adaptogenics Health (ADPT.CN) as of Oct 28, 2026 is -4.26. In the previous year, Forward P/E Ratio was -2.17 — a change of 96.52% (lower).

Forward P/E

-4.26

YoY

96.52%

Last updated:

Forward P/E Ratio of Adaptogenics Health is 2025 -4.26 . Forward P/E Ratio of Adaptogenics Health was 2024 -2.17 . It decreases by 96.52% lower compared to the previous year.

The Adaptogenics Health Forward P/E history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Forward P/E
Date
Forward P/E
Jan 1, 2022
-2.27 CAD
Jan 1, 2023
-1.20 CAD
Jan 1, 2024
-2.17 CAD
Jan 1, 2025
-4.26 CAD
The Adaptogenics Health Forward P/E history
YEARForward P/EYoY
-4.26+96.52%
-2.17+80.68%
-1.20-47.03%
-2.27—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Adaptogenics Health Stock analysis

What does Adaptogenics Health do? Adaptogenics Health Corp formulates and distributes functional mushroom products and nutritional supplement alternatives, focusing on combinations of functional mushrooms and adaptogens for holistic health. The company sells directly to consumers via its Website and wholesales to retailers across Canada, offering five mushroom liquid tonics: Reishi, Chaga, Turkey Tail, Lions Mane, and Cordyceps (Cultured Chinese Caterpillar Fungus). Its primary customers are health-conscious consumers seeking natural wellness solutions through direct-to-consumer and retail channels. The firm's product line includes liquid tonics featuring specific mushroom varieties, with Reishi, Chaga, Turkey Tail, Lions Mane, and Cordyceps being the core offerings. These products target consumers interested in holistic health and natural supplements, sold through direct e-commerce and Canadian retail partnerships. Adaptogenics Health Corp's revenue streams are derived from direct consumer sales and wholesale distribution to Canadian retailers, emphasizing functional mushroom-based wellness solutions. Adaptogenics Health is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Adaptogenics Health stock

Forward P/E Ratio of Adaptogenics Health is -4.26 in 2025.

Forward P/E Ratio of Adaptogenics Health changed from -2.17 to -4.26, representing a 96.52% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Forward P/E Ratio Adaptogenics Health since 2006 – with annual values, charts, and detailed analysis.

The Forward P/E uses estimated future earnings to value a stock. A lower forward P/E relative to the trailing P/E suggests analysts expect earnings growth.

To evaluate Forward P/E Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Forward P/E Ratio.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Forward P/E Ratio's Adaptogenics Health with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Adaptogenics Health

All Key Metrics — Adaptogenics Health